Skip to main content

and
  1. Article

    Open Access

    Author Correction: RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells

    A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.

    Nouar Qutob, Ikuo Masuho, Michal Alon, Rafi Emmanuel, Isadora Cohen in Scientific Reports (2019)

  2. Article

    Open Access

    RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells

    Analysis of 501 melanoma exomes revealed RGS7, which encodes a GTPase-accelerating protein (GAP), to be a tumor-suppressor gene. RGS7 was mutated in 11% of melanomas and was found to harbor three recurrent mutati...

    Nouar Qutob, Ikuo Masuho, Michal Alon, Rafi Emmanuel, Isadora Cohen in Scientific Reports (2018)

  3. No Access

    Article

    Recurrent inactivating RASA2 mutations in melanoma

    Yardena Samuels and colleagues report the analysis of 501 melanoma exomes and the identification of RASA2 as a tumor-suppressor gene mutated in 5% of melanomas. RASA2 mutations led to increased RAS activation, an...

    Rand Arafeh, Nouar Qutob, Rafi Emmanuel, Alona Keren-Paz, Jason Madore in Nature Genetics (2015)

  4. No Access

    Article

    YAP and the drug resistance highway

    Deciphering mechanisms of drug resistance is crucial to winning the battle against cancer. A new study points to an unexpected function of YAP in drug resistance and illuminates its potential role as a therape...

    Alona Keren-Paz, Rafi Emmanuel, Yardena Samuels in Nature Genetics (2015)